Clinical efficacy and short-term prognosis of belimumab in the treatment of systemic lupus erythematosus in children
Conventional glucocorticoid therapy combined with belimumab effectively enhances treatment outcomes in pediatric SLE patients, reduces the risk of short-term recurrence, and does not increase adverse reactions.
Authors
- Yu Ming Victor Fang (ORCID: https://orcid.org/0000-0003-3520-2780)
Institutions
- Chengdu Women's and Children's Central Hospital (CN)
Publication Details
- Journal
- American Journal of Translational Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.62347/lfkb9461
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00